Schroder Investment Management Group Buys 66,090 Shares of Cigna Group $CI

Key Points

• Schroder Investment Management Group raised its stake in Cigna by 53%, buying 66,090 shares to hold 190,710 shares worth about $54.97 million (roughly 0.07% of the company) at quarter-end.
• Cigna beat quarterly expectations (EPS $8.08 vs. $7.88; revenue $72.5B vs. $69.53B) and set FY2026 EPS guidance of 30.25, while analysts maintain a "Moderate Buy" consensus with a $330.42 average target.
• Cigna raised its quarterly dividend to $1.56 (annualized $6.24, ~2.4% yield), and insiders sold a combined 4,026 shares on March 2 at about $288.91, leaving insider ownership at 0.70%.

Schroder Investment Management Group raised its stake in shares of Cigna Group (NYSE:CI - Free Report) by 53.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 190,710 shares of the health services provider's stock after buying an additional 66,090 shares during the quarter. Schroder Investment Management Group owned about 0.07% of Cigna Group worth $54,972,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of CI. Harbor Capital Advisors Inc. raised its position in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider's stock worth $26,000 after purchasing an additional 49 shares during the last quarter. Collier Financial purchased a new stake in Cigna Group during the 3rd quarter valued at about $34,000. Traub Capital Management LLC bought a new stake in Cigna Group during the 2nd quarter valued at about $48,000. Twin Peaks Wealth Advisors LLC bought a new stake in Cigna Group during the 2nd quarter valued at about $52,000. Finally, CNB Bank raised its holdings in Cigna Group by 479.4% in the third quarter. CNB Bank now owns 197 shares of the health services provider's stock worth $57,000 after buying an additional 163 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CI shares. Leerink Partners upped their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a "market perform" rating in a research note on Friday, February 6th. Wall Street Zen upgraded shares of Cigna Group from a "hold" rating to a "buy" rating in a report on Saturday, February 7th. Mizuho set a $325.00 price objective on Cigna Group in a research report on Friday, January 9th. Piper Sandler cut their target price on Cigna Group from $374.00 to $370.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 3rd. Finally, Guggenheim reissued a "buy" rating and issued a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group has an average rating of "Moderate Buy" and a consensus target price of $330.42.

Insider Buying and Selling at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company's stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by corporate insiders.

Cigna Group Stock Performance

Shares of CI stock opened at $262.13 on Wednesday. The company has a 50 day moving average price of $280.29 and a 200-day moving average price of $283.45. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The firm has a market capitalization of $69.08 billion, a PE ratio of 11.82, a P/E/G ratio of 0.93 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analysts' expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is a boost from Cigna Group's previous quarterly dividend of $1.51. Cigna Group's dividend payout ratio (DPR) is presently 28.13%.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.